Paragraphs
Longer wear time
92% industry-leading real-world adherence.¹
Fully implantable 90-day sensor.
Continuous readings and alerts around the clock.
Selector Class
long-wear-time
Greater insight
Exceptional accuracy, especially in the 40-60 mg/dL range.²
Charts, graphs and in-app reports to improve glycemic awareness.
THREE TYPES OF ALERTS (AUDIO, ON BODY VIBRATIONS AND MOBILE TEXT) TO GUIDE SAFE MANAGEMENT.
Selector Class
greater_inside
Fewer obstacles
NO WEEKLY OR BI-MONTHLY SENSOR REPLACEMENTS.
Near-real time feedback to help predict and monitor trends.
Detects 95% of hyper/hypo events in 15 minutes.³
Selector Class
fewers-obstacles
Content
Improved self-management
59-69%
EXCEPTIONAL REAL-WORLD TIME IN TARGET.1
7.1%
REAL-WORLD GMI OF 7.1%1, BELOW ADA TREATMENT TARGET.4
Improved control reduces health risks and complications.5
Content CSS Selector
ism-top
Content Selector Id
ism-top
Paragraph
Mobile - Women Image
Content CSS Selector
ism-bottom
Content Selector Id
ism-bottom
Selector Id
eversense-payer-self-management
Selector Class
eversense-payer-self-management
To find out more about improvements in emotional burden and Quality of Life measures, download our study: Acceptability of Implantable Continuous Glucose Monitoring Sensor
Selector Class
product-sheet x-overflow
Selector Class
section-next
Selector Class
section-lists